美国四城市急诊科成人丙肝感染高流行:2015-2017年普遍筛查结果
2015-2016年间,美国四家城市急诊科对成人实施退出式普遍丙肝抗体筛查,共检测14,252例,抗-HCV阳性总体患病率为9.2%。1945-1965年出生队列阳性率为13.9%,其中非西班牙裔黑人(16.0%)显著高于非西班牙裔白人(12.2%);1965年后出生者总体阳性率为6.7%,白人(15.3%)显著高于黑人(3.2%)。
要点
- 城市急诊科成人抗-HCV总体阳性率达9.2%,提示该场景适合开展普遍筛查。
- 1945-1965年出生队列抗-HCV阳性率13.9%,黑人高于白人。
- 1965年后出生者抗-HCV阳性率6.7%,白人高于黑人。
核心结论
- 城市急诊科退出式普遍丙肝筛查可发现高比例抗-HCV阳性成人,有助于提高感染知晓和监测。
研究设计与样本
- 2015-2016年期间,美国伯明翰、奥克兰、巴尔的摩和波士顿四家城市急诊科对成人患者实施退出式普遍丙肝抗体筛查,共检测14,252例。
主要发现
- 成人患者总体抗-HCV阳性患病率为9.2%。
- 1945-1965年出生队列抗-HCV阳性率为13.9%,非西班牙裔黑人(16.0%)显著高于非西班牙裔白人(12.2%)(p<0.001)。
- 1965年后出生者总体抗-HCV阳性率为6.7%,非西班牙裔白人(15.3%)显著高于非西班牙裔黑人(3.2%)(p<0.001)。
关键数值与推荐
- CDC自2012年起建议对所有1945-1965年出生者进行慢性丙肝检测。
- 新推荐支持所有≥18岁成人至少一生检测一次丙肝,但阳性患病率<0.1%的场景除外。
临床怎么用
- 在城市急诊科可对成人采用退出式普遍抗-HCV筛查,以提高丙肝感染发现率。
- 筛查时应关注不同出生队列和种族/族裔间抗-HCV阳性率的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Identifying persons with hepatitis C virus (HCV) infection has become an urgent public health challenge because of increasing HCV-related morbidity and mortality, low rates of awareness among infected persons, and the advent of curative therapies (1). Since 2012, CDC has recommended testing of all persons born during 1945-1965 (baby boomers) for identification of chronic HCV infection (1); urban emergency departments (EDs) are well positioned venues for detecting HCV infection among these persons. The United States has witnessed an unprecedented opioid overdose epidemic since 2013 that derives primarily from commonly injected illicit opioids (e.g., heroin and fentanyl) (2). This injection drug use behavior has led to an increase in HCV infections among persons who inject drugs and heightened concern about increases in human immunodeficiency virus (HIV) and HCV infection within communities disproportionately affected by the opioid crisis (3,4). However, targeted strategies for identifying HCV infection among persons who inject drugs is challenging (5,6). During 2015-2016, EDs at the University of Alabama at Birmingham; Highland Hospital, Oakland, California; Johns Hopkins Hospital, Baltimore, Maryland; and Boston University Medical Center, Massachusetts, adopted opt-out (i.e., patients can implicitly accept or explicitly decline testing), universal hepatitis C screening for all adult patients. ED staff members offered HCV antibody (anti-HCV) screening to patients who were unaware of their status.* During similar observation periods at each site, ED staff members tested 14,252 patients and identified an overall 9.2% prevalence of positive results for anti-HCV among the adult patient population. Among the 1945-1965 birth cohort, prevalence of positive results for anti-HCV (13.9%) was significantly higher among non-Hispanic blacks (blacks) (16.0%) than among non-Hispanic whites (whites) (12.2%) (p<0.001). Among persons born after 1965, overall prevalence of positive results for anti-HCV was 6.7% and was significantly higher among whites (15.3%) than among blacks (3.2%) (p<0.001). These findings highlight age-associated differences in racial/ethnic prevalences and the potential for ED venues and opt-out, universal testing strategies to improve HCV infection awareness and surveillance for hard-to-reach populations. This opt-out, universal testing approach is supported by new recommendations for hepatitis C screening at least once in a lifetime for all adults aged ≥18 years, except in settings where the prevalence of positive results for HCV infection is <0.1% (7).
引用
- Galbraith JW, Anderson ES, Hsieh YH, et al. High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32407307. doi:10.15585/mmwr.mm6919a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。